Planned Parenthood Affiliate Turns to Botox to Offset Federal Funding Cuts
The largest Planned Parenthood affiliate in the United States is diversifying its revenue stream, now offering cosmetic procedures like Botox injections alongside its traditional reproductive health services.
The New Services
Planned Parenthood Mar Monte has begun offering Botox injections and IV hydration therapy at its Sacramento clinic. These services are available on a cash-pay basis only. The affiliate is charging $9 per unit of Botox, a price point that is 25 to 50% cheaper than other providers in the region.
"I'm excited about this as a way for patients to support the organization financially and for clinicians to offer treatments for migraines and gender-affirming care, in addition to cosmetic use." - Dr. Laura Dalton, Chief Medical Operating Officer
The affiliate is also exploring expansion into cosmetic fillers and GLP-1 weight-loss treatments, with Dr. Dalton indicating this model could serve as a blueprint for other clinics facing similar financial pressures.
The Financial Reality
The move is a direct response to significant federal funding cuts that prevent Planned Parenthood from accepting Medicaid reimbursement for non-abortion services. These cuts, part of a tax and spending package passed last year, are currently set to expire this summer but could be renewed.
The financial impact on Planned Parenthood Mar Monte has been severe:
- 75-80% of the affiliate's patients rely on Medi-Cal (California's Medicaid program)
- The affiliate has been forced to close five clinics since the cuts took effect
"About 75-80% of our patients are on Medi-Cal. We've had to close five clinics since these cuts took effect."
State Support and Criticism
California Governor Gavin Newsom and state lawmakers have allocated hundreds of millions of dollars to Planned Parenthood and similar organizations, including $90 million in February alone. However, leaders say it remains unclear whether this funding will be sufficient to cover core services in the long term.
The use of state funds has drawn sharp criticism from anti-abortion groups. Marjorie Dannenfelser, president of Susan B. Anthony Pro-Life America, characterized the initiative as a "Botox bailout."
Broader Implications
Critics have also raised cultural concerns. Jessica DeFino, a beauty critic and author, expressed concern that offering Botox could create an association between anti-aging procedures and feminism, which she argues is not aligned with the push for freedom from gender-based discrimination.
The development highlights the precarious financial position of reproductive health organizations navigating a complex landscape of federal restrictions and state-level support. As the summer expiration of the funding cuts approaches, the future of these services—and the clinics that rely on federal reimbursement—remains uncertain.